Rong Chu

601 total citations
25 papers, 463 citations indexed

About

Rong Chu is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Rong Chu has authored 25 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 6 papers in Cell Biology. Recurrent topics in Rong Chu's work include Microtubule and mitosis dynamics (6 papers), Cancer-related Molecular Pathways (6 papers) and Cell death mechanisms and regulation (5 papers). Rong Chu is often cited by papers focused on Microtubule and mitosis dynamics (6 papers), Cancer-related Molecular Pathways (6 papers) and Cell death mechanisms and regulation (5 papers). Rong Chu collaborates with scholars based in United States, Canada and Germany. Rong Chu's co-authors include Timothy C. Chambers, David Terrano, Meenakshi Upreti, Elena Galitovskaya, Susana Granell, Joshua M. Eichhorn, Alan J. Tackett, Nandini Sakurikar, Elisabeth I. Heath and Wen-Xing Ding and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Rong Chu

25 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rong Chu United States	12	277	184	96	79	35	25	463
Cheng‐Da Hsu Taiwan	14	382 1.4×	101 0.5×	50 0.5×	92 1.2×	56 1.6×	25	517
Jean-Pierre Roperch France	9	335 1.2×	164 0.9×	49 0.5×	75 0.9×	71 2.0×	10	503
Rodolfo Daniel Cervantes‐Villagrana Mexico	12	250 0.9×	116 0.6×	65 0.7×	47 0.6×	51 1.5×	26	496
Yuan Chang-ji China	9	250 0.9×	65 0.4×	59 0.6×	35 0.4×	48 1.4×	19	450
Soroush Tahmasebi United States	14	645 2.3×	112 0.6×	58 0.6×	40 0.5×	69 2.0×	27	815
Chiara Battistini Italy	11	256 0.9×	88 0.5×	68 0.7×	24 0.3×	58 1.7×	21	399
Nicole Grabinski Germany	11	368 1.3×	123 0.7×	43 0.4×	60 0.8×	106 3.0×	11	561
Yi‐Wen Chang Taiwan	12	326 1.2×	215 1.2×	53 0.6×	39 0.5×	150 4.3×	23	558
Rounak Nassirpour United States	10	340 1.2×	101 0.5×	78 0.8×	32 0.4×	125 3.6×	12	573

Countries citing papers authored by Rong Chu

Since Specialization

Citations

This map shows the geographic impact of Rong Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Chu more than expected).

Fields of papers citing papers by Rong Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Chu. The network helps show where Rong Chu may publish in the future.

Co-authorship network of co-authors of Rong Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Chu. A scholar is included among the top collaborators of Rong Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Chu. Rong Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dhakal, Binod, Andrew J. Yee, Paul G. Richardson, et al.. (2024). Initial Results of a Phase 1 First-in-Human Study of Cemsidomide (CFT7455), a Novel MonoDACTM Degrader, with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 144(Supplement 1). 3366–3366. 4 indexed citations

Horwitz, Steven M., Salvia Jain, Jacob D. Soumerai, et al.. (2024). Initial Results of a Phase 1 First-in-Human Study of Cemsidomide (CFT7455), a Novel MonoDACTM Degrader, in Patients with Non-Hodgkin's Lymphoma. Blood. 144(Supplement 1). 467–467. 4 indexed citations

McHugh, Deaglan Joseph, Mario A. Eisenberger, Elisabeth I. Heath, et al.. (2019). A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer. Investigational New Drugs. 37(5). 1052–1060. 19 indexed citations

Petrylak, Daniel P., Raymond P. Perez, Jingsong Zhang, et al.. (2017). A phase I study of enfortumab vedotin (ASG-22CE; ASG-22ME): Updated analysis of patients with metastatic urothelial cancer.. Journal of Clinical Oncology. 35(15_suppl). 106–106. 23 indexed citations

Rosenberg, Jonathan E., Elisabeth I. Heath, Raymond P. Perez, et al.. (2016). Interim analysis of a phase I dose escalation trial of ASG-22CE (ASG-22ME; enfortumab vedotin), an antibody drug conjugate (ADC), in patients (Pts) with metastatic urothelial cancer (mUC). Annals of Oncology. 27. vi273–vi273. 9 indexed citations

Chu, Rong, et al.. (2016). Mitotic arrest-induced phosphorylation of Mcl-1 revisited using two-dimensional gel electrophoresis and phosphoproteomics: nine phosphorylation sites identified. Oncotarget. 7(48). 78958–78970. 8 indexed citations

Petrylak, Daniel P., Elisabeth I. Heath, Guru Sonpavde, et al.. (2016). Interim analysis of a phase I dose escalation trial of the antibody drug conjugate (ADC) AGS15E (ASG-15ME) in patients (Pts) with metastatic urothelial cancer (mUC). Annals of Oncology. 27. vi269–vi269. 27 indexed citations

Rosenberg, Jonathan E., Elisabeth I. Heath, Peter J. Van Veldhuizen, et al.. (2016). Anti-tumor activity, safety and pharmacokinetics (PK) of ASG-22CE (ASG-22ME; enfortumab vedotin) in a phase I dose escalation trial in patients (Pts) with metastatic urothelial cancer (mUC).. Journal of Clinical Oncology. 34(15_suppl). 4533–4533. 6 indexed citations

Petrylak, Daniel P., Elisabeth I. Heath, Guru Sonpavde, et al.. (2016). Anti-tumor activity, safety and pharmacokinetics (PK) of AGS15E (ASG-15ME) in a phase I dose escalation trial in patients (Pts) with metastatic urothelial cancer (mUC).. Journal of Clinical Oncology. 34(15_suppl). 4532–4532. 9 indexed citations

10.

Chu, Rong, et al.. (2013). Helicobacter pylori infection and expressions of apoptosis-related proteins p53, ASPP2 and iASPP in gastric cancer and precancerous lesions. Pathologie Biologie. 61(5). 199–202. 15 indexed citations

11.

Chu, Rong & Timothy C. Chambers. (2013). Abstract 1739: Unexpected complexity in Mcl-1 phosphorylation in response to microtubule inhibitors.. Cancer Research. 73(8_Supplement). 1739–1739. 1 indexed citations

12.

Eichhorn, Joshua M., et al.. (2013). Critical role of anti-apoptotic Bcl-2 protein phosphorylation in mitotic death. Cell Death and Disease. 4(10). e834–e834. 51 indexed citations

13.

Chu, Rong, et al.. (2012). Metabolic Transformation of Antitumor Acridinone C-1305 but Not C-1311 via Selective Cellular Expression of UGT1A10 Increases Cytotoxic Response: Implications for Clinical Use. Drug Metabolism and Disposition. 41(2). 414–421. 16 indexed citations

14.

Chu, Rong, David Terrano, & Timothy C. Chambers. (2011). Cdk1/cyclin B plays a key role in mitotic arrest-induced apoptosis by phosphorylation of Mcl-1, promoting its degradation and freeing Bak from sequestration. Biochemical Pharmacology. 83(2). 199–206. 54 indexed citations

15.

Chu, Rong, David Terrano, & Timothy C. Chambers. (2009). Abstract #4601: Phosphorylation and degradation of Mcl-1 in vinblastine-induced apoptosis. Cancer Research. 69. 4601–4601. 1 indexed citations

16.

Chu, Rong, Meenakshi Upreti, Wen-Xing Ding, Xiao‐Ming Yin, & Timothy C. Chambers. (2009). Regulation of Bax by c-Jun NH2-terminal kinase and Bcl-xL in vinblastine-induced apoptosis. Biochemical Pharmacology. 78(3). 241–248. 24 indexed citations

17.

Upreti, Meenakshi, et al.. (2008). Key role for Bak activation and Bak-Bax interaction in the apoptotic response to vinblastine. Molecular Cancer Therapeutics. 7(7). 2224–2232. 36 indexed citations

18.

Upreti, Meenakshi, Elena Galitovskaya, Rong Chu, et al.. (2008). Identification of the Major Phosphorylation Site in Bcl-xL Induced by Microtubule Inhibitors and Analysis of Its Functional Significance. Journal of Biological Chemistry. 283(51). 35517–35525. 73 indexed citations

19.

Kadekaro, Massako, et al.. (2006). Effects of nitric oxide on expressions of nitrosocysteine and calcium-activated potassium channels in the supraoptic nuclei and neural lobe of dehydrated rats. Neuroscience Letters. 411(2). 117–122. 10 indexed citations

20.

Kadekaro, Massako, et al.. (2006). Nitric oxide up-regulates the expression of calcium-dependent potassium channels in the supraoptic nuclei and neural lobe of rats following dehydration. Neuroscience Letters. 404(1-2). 50–55. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact